BNP Paribas Financial Markets’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,349
| Closed | -$654 | – | 4220 |
|
|
2020
Q4 | $654 | Sell |
1,349
-3,877
| -74% | -$1.96K | ﹤0.01% | 4041 |
|
|
2020
Q3 | $2.84K | Sell |
5,226
-32,452
| -86% | -$23.3K | ﹤0.01% | 4047 |
|
|
2020
Q2 | $26K | Buy |
37,678
+11,723
| +45% | +$9.43K | ﹤0.01% | 3278 |
|
|
2020
Q1 | $21.9K | Buy |
25,955
+14,531
| +127% | +$20.8K | ﹤0.01% | 3889 |
|
|
2019
Q4 | $18.7K | Buy |
11,424
+788
| +7% | +$1.18K | ﹤0.01% | 4018 |
|
|
2019
Q3 | $11.8K | Sell |
10,636
-914
| -8% | -$1.06K | ﹤0.01% | 4117 |
|
|
2019
Q2 | $14.3K | Sell |
11,550
-620
| -5% | -$789 | ﹤0.01% | 4012 |
|
|
2019
Q1 | $17.5K | Buy |
12,170
+5,391
| +80% | +$7.99K | ﹤0.01% | 3931 |
|
|
2018
Q4 | $8K | Buy |
6,779
+3,929
| +138% | +$5.83K | ﹤0.01% | 3425 |
|
|
2018
Q3 | $3.85K | Sell |
2,850
-784
| -22% | -$1.24K | ﹤0.01% | 4143 |
|
|
2018
Q2 | $8.32K | Sell |
3,634
-9,198
| -72% | -$17.8K | ﹤0.01% | 3869 |
|
|
2018
Q1 | $19.4K | Sell |
12,832
-318
| -2% | -$373 | ﹤0.01% | 3933 |
|
|
2017
Q4 | $10K | Buy |
13,150
+9,005
| +217% | +$8.05K | ﹤0.01% | 4033 |
|
|
2017
Q3 | $4.81K | Sell |
4,145
-303
| -7% | -$382 | ﹤0.01% | 3984 |
|
|
2017
Q2 | $7.74K | Buy |
4,448
+3,864
| +662% | +$8.21K | ﹤0.01% | 3992 |
|
|
2017
Q1 | $1.54K | Sell |
584
-1,317
| -69% | -$4.73K | ﹤0.01% | 3608 |
|
|
2016
Q4 | $8.08K | Sell |
1,901
-8,254
| -81% | -$27.2K | ﹤0.01% | 3549 |
|
|
2016
Q3 | $27.1K | Sell |
10,155
-168
| -2% | -$386 | ﹤0.01% | 2725 |
|
|
2016
Q2 | $18.3K | Buy |
10,323
+573
| +6% | +$1.17K | ﹤0.01% | 2622 |
|
|
2016
Q1 | $22.6K | Sell |
9,750
-5,806
| -37% | -$13.1K | ﹤0.01% | 2142 |
|
|
2015
Q4 | $54K | Buy |
15,556
+7,977
| +105% | +$38.2K | ﹤0.01% | 2762 |
|
|
2015
Q3 | $46.5K | Buy |
7,579
+4,530
| +149% | +$30.7K | ﹤0.01% | 2919 |
|
|
2015
Q2 | $20.1K | Buy |
3,049
+2,507
| +463% | +$16.9K | ﹤0.01% | 3052 |
|
|
2015
Q1 | $3.86K | Buy |
+542
| New | +$4.09K | ﹤0.01% | 3282 |
|
Other funds holding GEN
IC
TRCT
BNP Paribas Financial Markets's GEN Position: Q1 2021 in Review
BNP Paribas Financial Markets sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 1,349 shares — an estimated $654 sold.
BNP Paribas Financial Markets first reported a position in GEN in Q1 2015 and held it in 24 quarters. The position peaked at $54K in Q4 2015. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.
- BNP Paribas Financial Markets reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
- BNP Paribas Financial Markets sold 1,349 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $654.
- BNP Paribas Financial Markets first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 24 quarters.
- BNP Paribas Financial Markets's Genesis Healthcare, Inc. position peaked at $54K in Q4 2015.
- 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2021, filed 7 May 2021.